A new cost-effective, simple blood test could be the answer to accurately diagnosing and treating Alzheimer's Disease.

The test is able to detect how much of the disease is in the brain, and how advanced the Alzheimer's is allowing for more targeted therapies. 

Leading Alzheimer’s researcher based at The Florey, Austin Health and Australian Dementia Network Professor Christopher Rowe told Milsy and Karl on 6PR Breakfast the test has the potential to revolutionise the treatment of Alzheimer's. 

See omnystudio.com/listener for privacy information.